Key facts
- This page summarizes Waldemar Priebe's Form 4 filing for CNS Pharmaceuticals, Inc. (CNSP).
- 17 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 01 Aug 2023, 17:10.
Waldemar Priebe - 06 Dec 2022 Form 4 Insider Report for CNS Pharmaceuticals, Inc. (CNSP)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- CNSP
- Reported as of
- 06 Dec 2022
- Net transaction value
- -$133,114
- SEC form
- 4
- Accepted by SEC
- 01 Aug 2023, 17:10:16 UTC
- Prior SEC filing
- 25 Jan 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Waldemar Priebe
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Waldemar Priebe filed Form 4 for CNS Pharmaceuticals, Inc. (CNSP) on 01 Aug 2023.
Change
- Previous filing in this sequence was filed on 25 Jan 2022.
- Current net transaction value: -$133,114.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CNSP
transaction
Common Stock
Sale
- Transaction value
- $13,585
- Shares
- -5,500
- Change %
- -2.2%
- Price
- $2.47
- Shares after
- 245,605
- Date
- 06 Dec 2022
- Ownership
- See footnote
- Footnotes
- F1
CNSP
transaction
Common Stock
Sale
- Transaction value
- $13,530
- Shares
- -5,500
- Change %
- -2.2%
- Price
- $2.46
- Shares after
- 240,105
- Date
- 07 Dec 2022
- Ownership
- See footnote
- Footnotes
- F1
CNSP
transaction
Common Stock
Sale
- Transaction value
- $13,200
- Shares
- -5,500
- Change %
- -2.3%
- Price
- $2.40
- Shares after
- 234,605
- Date
- 08 Dec 2022
- Ownership
- See footnote
- Footnotes
- F1
CNSP
transaction
Common Stock
Sale
- Transaction value
- $6,799
- Shares
- -2,798
- Change %
- -1.2%
- Price
- $2.43
- Shares after
- 231,807
- Date
- 09 Dec 2022
- Ownership
- See footnote
- Footnotes
- F1
CNSP
transaction
Common Stock
Sale
- Transaction value
- $6,450
- Shares
- -5,000
- Change %
- -2.2%
- Price
- $1.29
- Shares after
- 226,807
- Date
- 10 Mar 2023
- Ownership
- See footnote
- Footnotes
- F1
CNSP
transaction
Common Stock
Sale
- Transaction value
- $6,500
- Shares
- -5,000
- Change %
- -2.2%
- Price
- $1.30
- Shares after
- 221,807
- Date
- 13 Mar 2023
- Ownership
- See footnote
- Footnotes
- F1
CNSP
transaction
Common Stock
Sale
- Transaction value
- $6,750
- Shares
- -5,000
- Change %
- -2.3%
- Price
- $1.35
- Shares after
- 216,807
- Date
- 14 Mar 2023
- Ownership
- See footnote
- Footnotes
- F1
CNSP
transaction
Common Stock
Sale
- Transaction value
- $6,100
- Shares
- -5,000
- Change %
- -2.3%
- Price
- $1.22
- Shares after
- 211,807
- Date
- 15 Mar 2023
- Ownership
- See footnote
- Footnotes
- F1
CNSP
transaction
Common Stock
Sale
- Transaction value
- $6,200
- Shares
- -5,000
- Change %
- -2.4%
- Price
- $1.24
- Shares after
- 206,807
- Date
- 16 Mar 2023
- Ownership
- See footnote
- Footnotes
- F1
CNSP
transaction
Common Stock
Sale
- Transaction value
- $5,650
- Shares
- -5,000
- Change %
- -2.4%
- Price
- $1.13
- Shares after
- 201,807
- Date
- 17 Mar 2023
- Ownership
- See footnote
- Footnotes
- F1
CNSP
transaction
Common Stock
Sale
- Transaction value
- $5,400
- Shares
- -5,000
- Change %
- -2.5%
- Price
- $1.08
- Shares after
- 196,807
- Date
- 20 Mar 2023
- Ownership
- See footnote
- Footnotes
- F1
CNSP
transaction
Common Stock
Sale
- Transaction value
- $5,500
- Shares
- -5,000
- Change %
- -2.5%
- Price
- $1.10
- Shares after
- 191,807
- Date
- 21 Mar 2023
- Ownership
- See footnote
- Footnotes
- F1
CNSP
transaction
Common Stock
Sale
- Transaction value
- $5,400
- Shares
- -5,000
- Change %
- -2.6%
- Price
- $1.08
- Shares after
- 186,807
- Date
- 22 Mar 2023
- Ownership
- See footnote
- Footnotes
- F1
CNSP
transaction
Common Stock
Sale
- Transaction value
- $10,800
- Shares
- -10,000
- Change %
- -5.4%
- Price
- $1.08
- Shares after
- 176,807
- Date
- 23 Mar 2023
- Ownership
- See footnote
- Footnotes
- F1
CNSP
transaction
Common Stock
Sale
- Transaction value
- $5,400
- Shares
- -5,000
- Change %
- -2.8%
- Price
- $1.08
- Shares after
- 171,807
- Date
- 24 Mar 2023
- Ownership
- See footnote
- Footnotes
- F1
CNSP
transaction
Common Stock
Sale
- Transaction value
- $5,450
- Shares
- -5,000
- Change %
- -2.9%
- Price
- $1.09
- Shares after
- 166,807
- Date
- 27 Mar 2023
- Ownership
- See footnote
- Footnotes
- F1
CNSP
transaction
Common Stock
Sale
- Transaction value
- $10,400
- Shares
- -10,000
- Change %
- -6%
- Price
- $1.04
- Shares after
- 156,807
- Date
- 28 Mar 2023
- Ownership
- See footnote
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Waldemar Priebe is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 1 footnote
Footnote F1
Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc.